A coronavirus vaccine will be available to poorer countries for less than $3 a dose under a new partnership between the Gates Foundation and the Serum Institute of India, the world’s largest vaccine maker.
The collaboration is meant to ensure up to 100 million doses of a COVID-19 vaccine will be available for distribution quickly to low- and middle-income countries. The arrangement also provides an option to secure additional doses if needed.
The move comes as other governments around the world, especially in the U.S., are moving to quickly secure vaccine production and distribution rights with pharmaceutical companies.
The Gates Foundation partnership, which also includes Gavi, the Vaccine Alliance — an organization that helps negotiate and finance vaccines for poor countries — will provide upfront capital to the Serum Institute to help them increase manufacturing capacity now.
The goal is that, once a vaccine, or vaccines, gains regulatory approval, doses can be produced at scale for distribution for low-income countries as early as the first half of 2021. They will be priced at no more than $3 a dose…